Wednesday, July 8, 2026

biotech · Multiple Myeloma · Multiple Myeloma (MM) · CCCC

C4 Therapeutics

C4 Therapeutics trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

WATERTOWN, MA, USA HQ
2024 Founded
2 Employees
Public company Type
CCCC · NYSE Ticker
Company details
Status
Public
HQ
WATERTOWN, MA, USA
Founded
2024
Employees
2
Programs
4
Drugs
1
Patents
24
Intelligence · Clinical Trials

C4 Therapeutics clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to C4 Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

C4 Therapeutics trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for C4 Therapeutics.

  1. Cemsidomide — Phase 1

    Clinical update
  2. cemsidomide — Phase 2

    Clinical update
  3. CFT1946 — Phase 1

    Clinical update
  4. CFT8634 — Phase 1

    Clinical update

Trial registry

5 studies